Related Experiment Video
Updated: Aug 17, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Cdk2 kinase phosphorylates serine 315 of human p53 in vitro
B D Price1, L Hughes-Davies, S J Park
1Joint Center for Radiation Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Abstract:
DNA damage increases p53 protein levels and activates transcription of the p21 gene. The p21 protein binds to and inhibits cdk2 kinase, causing G1 arrest. Here, we have investigated if a p53 fusion protein is a substrate for cdk2 kinase in vitro. Cdk2 kinase was immunoprecipitated from NIH3T3 cells and allowed to phosphorylate a human p53-GST (glutathione-s-transferase) fusion protein. Cdk2 and cyclin E-cdk2 efficiently phosphorylated both wild-type (wt) and mutant p53-GST. Cdk2 immunoprecipitated from cells in Go and early G1 exhibited minimal p53 kinase activity, whereas cells in S-phase displayed high levels of p53 kinase activity. If NIH3T3 cells were X-ray irradiated to induce DNA damage, cdk2 p53 kinase activity was rapidly inhibited within 1 h, but had recovered by 4 h post irradiation. Mutation of serine 315 of p53 to alanine (p53-S315A) abolished phosphorylation by cdk2 kinase. However, wtp53 and p53-S315A were equally effective at activating transcription when cotransfected with a p53 reporter construct. The results demonstrate that ser 315 of p53 is phosphorylated by cdk2 in vitro. However, ser 315 of wtp53 is not required for transcriptional activity in vivo, suggesting that cdk2 phosphorylation of p53 may be involved in regulating other cellular functions of wtp53.
Insights
Cyclin-dependent kinase 2 (CDK2) phosphorylates the tumor suppressor protein p53 at serine 315. This specific phosphorylation by CDK2 does not affect p53
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Research
Background:
- DNA damage response involves p53 protein stabilization and p21 gene transcription.
- p21 protein inhibits CDK2 kinase, leading to G1 cell cycle arrest.
Purpose of the Study:
- To investigate if a p53 fusion protein serves as a substrate for CDK2 kinase in vitro.
- To determine the role of serine 315 in p53 phosphorylation and transcriptional activity.
Main Methods:
- Immunoprecipitation of CDK2 kinase from NIH3T3 cells.
- In vitro phosphorylation assays using human p53-GST fusion protein.
- Site-directed mutagenesis of serine 315 in p53.
- Reporter gene assays to assess transcriptional activity.
Main Results:
- CDK2 and cyclin E-CDK2 efficiently phosphorylated both wild-type (wt) and mutant p53-GST.
- p53 kinase activity of CDK2 was high in S-phase and inhibited by X-ray irradiation.
- Mutation of serine 315 to alanine abolished CDK2 phosphorylation, but did not affect transcriptional activity.
Conclusions:
- Serine 315 of p53 is a direct phosphorylation site for CDK2 in vitro.
- CDK2-mediated phosphorylation of p53 at serine 315 is not essential for its transcriptional activity in vivo.
- CDK2 phosphorylation of p53 may regulate other cellular functions beyond transcriptional activation.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle

